To include your compound in the COVID-19 Resource Center, submit it here.

Prolastin-C: Phase II started

Talecris began the double-blind, crossover, U.S. Phase II

Read the full 86 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE